Vedanta Biosciences Granted Third U.S. Patent Covering Methods Of Treating Infectious And Allergic Diseases With Bacterial Consortia
Subscribe to Gene Silencing/Gene Editing Horizon Discovery, Fulcrum Therapeutics Collaborate on Target Discovery Using CRISPR Screens
Sentien Biotechnologies CEO Brian Miller Featured in BioWorld™Today
Pagliucas build a Harvard home to nurture life science startups
Polaris cashes in its chips as Langer-backed Arsia is auctioned off to Eagle for up to $78M
Life Lab builds on cross-disciplinary approach
Harvard in Allston: Life Lab
Pop-up pill could stay in stomach to release drugs for days
The office space race
Slone Partners Interview With Dr. Johannes Fruehauf
